Cue Biopharma CUE
NASDAQ CUE
$18.89 -0.06 (-0.32%)
At close: Oct 22, 2026 · 4:00 PM EDT

Cue Biopharma (CUE) Long-Term Debt Issuances (2022)

Updated

Cue Biopharma's Long-Term Debt Issuances came in at $18,000 for FY2024.

Analysis

Cue Biopharma (CUE) Long-Term Debt Issuances (2022) Analysis & Trends

  • Per Business Quant, earlier years put Long-Term Debt Issuances at $10 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Cue Biopharma 119.17 Mn 28.44 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 4.70 Mn
Mar 31, 2022 10.00 Mn
API Access

Cue Biopharma Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=CUE&period=max&api_key=YOUR_API_KEY